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Abstract 
 
Nitrite in/on the skin has potent antimicrobial effects and is believed to act as a local nitric 
oxide (NO) reservoir capable of modulating dermal cell function. Using male Wistar rats we 
here show that nitrite, when applied in neutral aqueous solution to the skin surface, readily 
permeates the dermis to reach the systemic circulation and cause widespread nitros(yl)ation 
of tissue proteins. These events extend to all internal organs investigated including 
compartments crucial for the regulation of immune cell function such as thymus, spleen and 
lymph nodes. Using a transgenic mouse model of allergic asthma, we further find that 
systemic nitrite administration potently suppresses the number of T-cells and other 
inflammatory cells and the production of the Th2 effector cytokine, IL-13 in the lung. Thus, 
nitrite formed via reduction of nitrate or oxidation of ammonia on the skin, may exert 
previously unappreciated systemic effects akin to NO. These observations have the potential 
to shift the current emphasis of nitrite from cardiovascular pharmacology to immunology. 
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TO THE EDITOR 
 
Whereas  systemic  administration  of  nitrite  (NO2
-)  affords  protection  against 
ischemia/reperfusion-related organ damage (Lundberg et al., 2008), topical nitrite application 
exerts local antimicrobial effects and promotes wound healing (Weller et al., 2001; 2006). 
The latter two actions require acidification, are often accompanied by increased blood flow 
(Tucker et al., 1999; Gribbe et al., 2008) and thought to be mediated by the formation of 
nitric oxide (NO), albeit not all effects of nitrite necessarily occur through NO generation 
(Bryan  et  al.,  2005).  While  the  significance  of  NO  in  cutaneous  physiology  is  widely 
recognized (Bruch-Gerharz et al., 1998; Weller, 2003) relevance and biological function of 
its oxidation product, nitrite, are incompletely understood (Suschek et al., 2006), as is how 
dermal nitrite couples to systemic NO/nitrite physiology. 
Nitrite concentrations in human skin are considerably higher than those in circulation 
(Paunel et al., 2005; Mowbray et al., 2009) and a reflection of local nitric oxide synthase 
activity. Nitrite is also a constituent of human sweat, possibly from reduction of nitrate by 
commensal heterotrophic bacteria colonizing the skin (Weller et al., 1996). The actions of 
nitrite in/on the skin have been proposed to contribute to host defense against skin pathogens 
and include modulation of cutaneous T-cell function, keratinocyte differentiation, blood flow, 
and  protection  against  UV-radiation  damage  (Weller  et  al.,  1996;  Suschek  et  al.,  2006). 
Whether  these  action  of  nitrite  extends  beyond  the  skin  is  unknown.  Recently,  nitrite 
production via autotrophic oxidation of ammonia by the dermal microflora has been proposed 
to contribute to bodily NO status and immune system function (Whitlock & Feelisch, 2009). 
An important prerequisite for the validity of this concept is nitrite’s ability to permeate the 
skin. While substances with a molecular weight of <500 Dalton are believed to cross the 
stratum  corneum  with  ease  (Bos  &  Meinardi,  2000),  the  same  rules  may  not  apply  for 4   
negatively-charged  ions 
1 .  Apart  from  anecdotal  evidence  of  fatal  methemoglobinemia 
following application of a liniment containing large quantities of nitrite (Saito et al., 1996; 
1997),  no  information  on  dermal  nitrite  uptake  is  available.  We  therefore  sought  to 
investigate, using a rodent model, whether nitrite permeates the skin to reach internal organs 
via the circulation. 
Pharmacologically relevant doses of nitrite (0.1, 1.0, and 10 mg
.kg-1 in PBS; pH=7.4) 
or vehicle were topically applied in equal volumes (800 µL) to a shaved area of the dorsal 
skin, and concentrations of several NO-related metabolites  (nitrite, nitrate, S- and N-nitroso 
(RXNO), and NO-heme species) were determined simultaneously in multiple compartments 
using  extensively  validated  ion-chromatographic  and  gas-phase  chemiluminescence-based 
techniques (Feelisch et al., 2002; Rodriguez et al., 2003; Bryan et al., 2004) (see Online- 
Supplement for details). We find i) that  no acidification is required to increase NO-related 
metabolites in blood and tissues, and ii) that compartments where increases occur include 
those important for priming and functional modulation of immune cells (thymus, spleen, and 
peripheral  lymph  nodes).      Since  all  NO-related  metabolites  determined  can  either  be 
metabolized  to  NO  or  are  endowed  with  NO-like  bioactivities,  dermal  nitrite  application 
would seem to lead to global increases in NO availability with consequent modulation of 
organ  and  immune  cell  function.  In  support  of  this  notion,  nitrite  was  found  to  potently 
inhibit T-cell and other inflammatory cell accumulation in the lung and airway secretion of 
IL-13 in a murine model of allergic asthma. 
 
While nitrite penetration through skin per se is perhaps not surprising, the speed and 
efficacy with  which this process occurred was  unexpected.  Dose-proportional increases in 
NO-related metabolites were monitored in three representative compartments (plasma, heart, 
and  liver)  and  became  evident  within  minutes  of  nitrite  application,  with  concentrations 
 
 
 
1 Nitrous acid (HNO2) has a pka of 3.4 and is thus largely (>99.9%) dissociated at physiological pH. 5   
peaking  within  5-15  min,  depending  on  the  compartment  under  study  (Fig.  1,  inset(s)). 
Maximal  concentrations  of  NO-related  metabolites  were  3-6  fold  lower  following  dermal 
application  compared  to  intraperitoneal  administration  of  equivalent  doses  (Bryan  et  al., 
2005), but no effort was undertaken to directly compare rates and extent of uptake between 
application routes. Topical administration of nitrite-free vehicle did not significantly change 
basal  levels  (not  shown).  Figure  1  depicts  the  effects  of  10  mg
.kg
-1  nitrite,  15  min  post 
application. Marked increases in nitrite, nitrate, RXNO and NO-heme species were seen in 
most,  but  not  all  compartments.  Notable  exceptions  were  kidney  (nitrite),  brain  (nitrate, 
RXNO, NO-heme), and plasma (RXNO, NO-heme) where either no change or a decrease of 
select NO-related metabolites occurred. Robust increases in circulating nitrite in conjunction 
with  lack  of  enhancement  of  plasma  nitrosation  products  suggests  S-nitrosoalbumin  plays 
only a minor role in transferring NO equivalents from skin to other organs, at least under 
these  conditions.  Therefore,  the  majority  of  metabolic  conversion  into  other  NO-related 
species likely occurs within blood cells and tissues. 
While there is precedence for increased NO-related metabolites in blood and tissues 
following systemic nitrite administration (Bryan et al., 2005), information about its effects on 
the immune system is scarce (Ustyugova et al., 2002; Cape & Hurst, 2009).   Lymph nodes 
from   vehicle-treated   animals   revealed   remarkably   high   nitrite/nitrate   concentrations, 
indicative  of  high  NO  production  rates  under  basal  conditions  (Table  1).  Dermal  nitrite 
application  (10  mg
.kg
-1)  induced  widespread  changes  in  NO-related  metabolites  within 
 
thymus,  spleen,  and  peripheral  lymph  nodes,  depicting  clear  increases  for  most,  except 
RXNO  which  decreased  in  thymus  and  lymph  nodes.  Preliminary  analysis  of  the  CD3- 
positive cell fraction of lymph nodes confirmed that although intracellular nitrite and nitrate 
concentrations double, S-nitrosation of T-cells drops by 45-60% shortly after dermal nitrite 
application. While little is known about effects of changes in protein nitrosation on immune 6   
cell activity, various functional consequences are likely considering the importance of redox- 
based signalling (Janssen-Heininger et al., 2008) and the versatility of NO in regulating T- 
cell, dendritic cell, and macrophage function in particular and immune responses in general 
(Bogdan, 2001; Niedbala et al., 2006). 
Cells  oxidize  NO  to  nitrite,  and  nitrite  can  be  reduced  back  to  NO  under  certain 
conditions; yet, the biology of these two species is not interchangeable and actions of nitrite 
cannot be simply inferred from known effects of NO. We therefore sought to obtain direct 
evidence for immunomodulation by nitrite in T-cell receptor transgenic mice challenged with 
aerosolized ovalbumin. Using this model of allergic asthma (Wilder et al, 2001) we found 
that nitrite (10 mg/L administered for 4 days with the drinking water) potently inhibits the 
number of T-lymphocytes and other inflammatory cells as well as the production of the Th2- 
derived effector cytokine, IL-13 in bronchial alveolar lavage fluid (Supplementary Fig.1). 
Collectively, our findings suggest that dermal nitrite administration provides a simple, 
non-invasive  alternative  to  other  application  forms  that  can  be  conveniently  utilized  for 
percutaneous  systemic  therapy  (presumably  with  lower  risk  of  N-nitrosamine  formation 
compared   to   oral   application).   Our   results   may   also   have   important   physiological 
implications inasmuch as sweat-derived nitrite, from nitrate reduction or ammonia oxidation, 
appears to have the potential to affect immune responses via modulation of NO availability. 
Further investigations  are warranted to confirm  our findings  and explore their therapeutic 
potential. 
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Table  1.    NO-related  metabolites  in  immune-relevant  compartments  15  min  post  dermal 
application of 10 mg
.kg-1 sodium nitrite (in PBS, pH 7.4) compared to effects of vehicle 
(PBS)  alone.  The  compartment  denoted  as  “lymph  nodes”  is  a  homogenate  of  pooled 
superficial cervical, anxillary, and iliac lymph nodes (ND = not determined due to limited 
sample availability). Data are means ± SEM from n individual experiments and expressed as 
nmoles/g wet weight (for nitrite, nitrate, and RXNO) and pmoles/g wet weight for NO-Heme 
products; *P<0.05, **P<0.01 vs. vehicle. 
 
 
 
 
    Vehicle  Nitrite 
    (n=5)  (n=3) 
Thymus  Nitrite  0.07±0.04 
Nitrate  2.96±0.64 
RXNO  0.24±0.06 
NO-Heme  4.34±2.97 
3.36±1.33* 
5.13±1.56 
0.20±0.02 
11.6±1.9 
 
 
 
Spleen 
 
Nitrite  <0.04 
 
Nitrate  1.17±0.15 
 
RXNO  0.09±0.01 
 
NO-Heme  1.24±0.85 
1.44±0.57* 
 
5.92±1.00** 
 
0.99±0.46* 
 
12.2±5.86* 
 
 
 
Lymph Nodes  Nitrite  3.71±1.29 
 
Nitrate  40.78±25.21 
 
RXNO  0.08±0.05 
 
NO-Heme  ND 
8.53±1.91 
 
84.25±42.29 
 
0.04±0.02 
 
ND 
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Figure 1. 
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Figure 1.  Concentration of NO-related metabolites in blood and tissues 15 min post-dermal 
application of pH-neutral solutions of sodium nitrite (10 mg
.kg-1; n=3) or vehicle (n=5) (A- 
D).  NO-related metabolites measured include nitrite, nitrate, S- and N- nitroso (RXNO), and 
nitrosyl (NO-heme) species.  With exception of brain, which revealed no change (RXNO, 
NO-heme) or decreased (nitrate) concentrations along with kidney (nitrite), appreciable 
increases in NO-related metabolites were seen in other compartments. Significant nitrite 
oxidation appears to occur only in blood, heart and kidney. Insets: Time courses of uptake 
and metabolism of dermal nitrite for three representative compartments (plasma, heart, liver). 
Within minutes marked increases in NO-related metabolites (nitrite, nitrate, RXNO, NO- 
heme) were evident. (RBC, red blood cell; bql, below quantifiable limit;  *p<0.05, **p<0.01 
vs. vehicle). 1   
SUPPLEMENTARY INFORMATION 
 
 
 
Materials and Methods 
 
Experimental Animals 
 
Male Wistar rats (250-300 g, Harlan) were kept on a regular 12h/12h 
light/dark cycle and allowed to acclimatize for at least 10d to local vivarium 
conditions prior to experimental use, with access to food (2018 rodent chow, Harlan 
Teklad) and regular tap water ad libitum.  All experiments were performed at the 
same time of day to keep chronobiological differences to a minimum (8:30-10:30 
a.m.).  DO11.10 mice (Jackson Laboratory) were maintained on an ovalbumin-free 
diet using identical housing conditions and allowed unlimited access to food and tap 
water. All animal experimental protocols were approved by the Institutional Animal 
Care and Use Committee at Boston University School of Medicine. 
 
 
 
Dermal Application of Nitrite 
 
Aqueous solutions of sodium nitrite (NaNO2) were prepared in phosphate 
buffered saline (PBS; pH 7.4) immediately before use. A 2 x 4 cm section of the 
dorsal rat skin was gently shaved in the area just below the neck using a small 
cordless hair clipper 22-24h prior to nitrite application to minimize handling-related 
stress on the day of experimentation.  Great care was taken to avoid skin irritation. 
Various nitrite doses were tested (0.1, 1.0, 10 mg kg
-1 NaNO2) and compared to the 
effect of the vehicle (PBS). Identical application volumes (800 µL) of test solutions 
 
(with nitrite concentrations adjusted according to animal weight) were applied to the 
shaved rat skin and evenly distributed across the defined area using the index finger 
(glove-covered). A time-course study (5, 15, 30, 60 min) was performed using a 10 2   
mg kg
-1 dose of nitrite and results were compared to application of an identical 
volume of PBS at 15 min which served as the basal value. 
 
 
 
Organ Harvest and Homogenization 
 
Heparinized (0.07 units/g body weight, i.p.) rats were anesthetized with 
diethylether (2 min) and euthanized by cervical dislocation.  Blood was withdrawn 
from the inferior vena cava and immediately centrifuged at 4,600 x g for 8 min at 
room temperature (22°C) to separate red blood cells (RBC) from plasma.  RBC were 
subjected to hypotonic lysis in water containing NEM (10 mM) and EDTA (2.5 mM). 
To remove blood for tissue analysis, organs were perfused in situ with room air- 
equilibrated PBS supplemented with NEM (10 mM) and EDTA (2.5 mM) for 1-2 min 
via the infrarenal part of the abdominal aorta, as described previously (Bryan et al., 
2004).  Brain, heart, liver, kidney, lung, aorta, thymus, spleen, and lymph nodes were 
harvested sequentially, homogenized, and subjected to immediate analysis. 
 
 
 
Lymphocytes isolation and flow cytometric/cell imaging analysis 
 
Pooled mesenteric, axillary and cervical lymph nodes, harvested from a 
separate group of animals within 3-5 min after sacrifice, were immersed in ice-cold 
PBS, trimmed free of fat and adherent tissue, chopped into small pieces in a Petri 
dish, and  passed through a cell strainer (BD Falcon; 100 µm). Aliquots of the 
resultant cell suspension (16-24 x 10
6 cells/mL) were used for protein determination, 
 
quantification of NO metabolites (after addition of NEM/EDTA and homogenization 
as described above), cell counting and fluorescence-activated cell sorting analysis 
(following a standard staining protocol using anti-CD3 antibodies from Daco). Under 
these conditions, 55-60% of the cells showed CD3-positive staining, with the 3   
remainder consisting of dendritic cells, B-cells, macrophages and nodal cells as 
judged by microscopic examination following hematoxylin/eosin staining. 
 
 
 
Quantification of NO oxidation, total nitrosation and nitrosylation products 
Methods for the detection of nitrosation (the sum of S- and N-nitroso species, RXNO) 
and nitrosyl (NO-heme) compounds, as well as the oxidation products of NO (nitrite 
and nitrate), in blood and tissues have been detailed previously (Feelisch et al., 2002; 
Bryan et al., 2004).  Quantification was achieved by group-specific denitrosation after 
injection of biological samples into either a triiodide-containing reaction mixture 
(RXNO species) or a potassium ferricyanide solution (NO-heme species) constantly 
purged with nitrogen, and NO was measured with the aid of a gas phase 
chemiluminescence detector (CLD 77am sp, EcoPhysics) under reduced ambient light 
(<15 lux) to prevent photolytic decomposition of NO adducts (Rodriguez et al., 
2003).  Nitrite and nitrate concentrations were quantified by ion-chromatography 
(ENO20, Eicom). Protein concentrations were determined using a commercial 
Bradford assay (Coomassie Plus, Pierce). 
 
 
 
Allergic Asthma Model 
 
The effects of nitrite on T-cell specific immunestimulation was investigated in 
ovalbumin (OVA)-challenged DO11.10 mice. These transgenic mice harbour an 
OVA-specific T-cell receptor that recognizes the OVA peptide 323-339 and react to 
short exposures of aerosolized OVA with exacerbated airway responsiveness without 
requiring prior immunization. Mice used in this study were 6-7 months of age. 
Immediately before start of the experiment, animals were switched to a low NOx diet 
(TD 99396, Harlan Teklad) and divided into 3 groups (3 animal/group), a control 4   
group receiving Milli-Q water, a low nitrite (10 mg/L NaNO2 in Milli-Q water) and 
an intermediate nitrite group (100 mg/L NaNO2 in Milli-Q water). At the day of 
randomization into different groups, three (control) and two (treatment groups) mice 
from each group were began to be exposed to a single daily challenge of aerosolized 
OVA (5% in PBS, 20 min exposure; Pari nebulizer) using a custom-made restraint- 
free inhalation chamber; one animal of either treatment group served as control for 
nitrite treatment alone. On the 4
th day of immunostimulation and 2h after the last 
OVA challenge mice were euthanized using pentobarbital and lungs were flushed 
with 4x1 mL aliquots of cold PBS to obtain bronchial alveolar lavage (BAL) fluid. 
Inflammatory cell counts and T-cell-specific counts in BAL fluid were determined by 
light microscopy after staining with haematoxylin/eosin and anti-CD3 antibodies, 
respectively, using air-dried slides prepared by cytocentrifugation (Cytospin III). IL- 
13 concentration in BAL was determined using a commercially available ELISA 
(R&D Systems). 5   
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Supplemental Figure 1:  Effects of nitrite on ovalbumin-induced airway 
inflammation and cytokine production in DO11.10 mice. 
Nitrite (10 mg/L NaNO2 in Milli-Q water) potently suppresses overall number of 
inflammatory cells (A), T-cell counts (B) and IL-13 production (C) in bronchiolar 
alveolar lavage (BAL) fluid of mice immunostimulated with aerosolized ovalbumin 
(5% in PBS, single 20 min exposure/day for 4 days). Mean data from two (nitrite) and 
three (control) animals/group, respectively. While nitrite was tolerated well in the 
absence of concomitant immunostimulation, ovalbumin-exposed animals on 100 
mg/L nitrite died on day 1 and 2, respectively. 